LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 1 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 1. - Dataset (ID:20309)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 47.11 | 771.67 | 5066 | 5941 | 0.8527 | 0.8946 | MN20160304_L01 | C19 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 47.11 | 771.67 | 5339 | 5941 | 0.8986 | 0.9287 | MN20160304_L01 | D12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 49.33 | 771.67 | 5484 | 6392 | 0.8579 | 0.9020 | MN20160304_L01 | C19 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 49.33 | 771.67 | 5661 | 6392 | 0.8856 | 0.9219 | MN20160304_L01 | D12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 51.55 | 771.67 | 5925 | 6829 | 0.8675 | 0.9117 | MN20160304_L01 | C19 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 51.55 | 771.67 | 5988 | 6829 | 0.8768 | 0.9181 | MN20160304_L01 | D12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 53.77 | 771.67 | 6220 | 7256 | 0.8572 | 0.9069 | MN20160304_L01 | C19 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 53.77 | 771.67 | 6419 | 7256 | 0.8846 | 0.9256 | MN20160304_L01 | D12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 55.99 | 771.67 | 6611 | 7690 | 0.8597 | 0.9109 | MN20160304_L01 | C19 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 55.99 | 771.67 | 6780 | 7690 | 0.8817 | 0.9255 | MN20160304_L01 | D12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 58.21 | 771.67 | 7026 | 8085 | 0.8690 | 0.9188 | MN20160304_L01 | C19 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 58.21 | 771.67 | 7148 | 8085 | 0.8841 | 0.9286 | MN20160304_L01 | D12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 60.44 | 771.67 | 7446 | 8530 | 0.8729 | 0.9231 | MN20160304_L01 | C19 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 60.44 | 771.67 | 7445 | 8530 | 0.8727 | 0.9230 | MN20160304_L01 | D12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 62.66 | 771.67 | 7711 | 8978 | 0.8588 | 0.9159 | MN20160304_L01 | C19 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 62.66 | 771.67 | 8000 | 8978 | 0.8910 | 0.9359 | MN20160304_L01 | D12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 64.88 | 771.67 | 8118 | 9447 | 0.8593 | 0.9178 | MN20160304_L01 | C19 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 64.88 | 771.67 | 8307 | 9447 | 0.8793 | 0.9301 | MN20160304_L01 | D12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 67.10 | 771.67 | 8555 | 9800 | 0.8729 | 0.9272 | MN20160304_L01 | C19 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 67.10 | 771.67 | 8602 | 9800 | 0.8777 | 0.9301 | MN20160304_L01 | D12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 69.32 | 771.67 | 8940 | 10212 | 0.8754 | 0.9299 | MN20160304_L01 | C19 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 69.32 | 771.67 | 8845 | 10212 | 0.8661 | 0.9243 | MN20160304_L01 | D12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 71.54 | 771.67 | 9162 | 10532 | 0.8699 | 0.9274 | MN20160304_L01 | C19 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 71.54 | 771.67 | 9043 | 10532 | 0.8586 | 0.9207 | MN20160304_L01 | D12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 73.76 | 771.67 | 9478 | 10851 | 0.8734 | 0.9303 | MN20160304_L01 | C19 |